Thermo Fisher Scientific’s Mass Spectrometry Technology Helps Children’s Hospital Boston Isolate Biomarker for Acute Pediatric Appendicitis
publication date: Dec 14, 2009
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that a team of researchers at Children’s Hospital Boston identified a promising biomarker, known as LRG, that they believe will help physicians diagnose acute pediatric appendicitis more accurately and efficiently.
To gain access to the members only content click here to join our community
You will be given immediate access to premium content on the site.